Enhancing the pharmacokinetic properties of recombinant factor VIII: first-in-human trial of glycoPEGylated recombinant factor VIII in patients with hemophilia A

Overview of attention for article published in Journal of Thrombosis & Haemostasis, April 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

patent: 10 patents

guideline: 1 clinical guideline source

Readers on

mendeley: 81 Mendeley

So far, Altmetric has seen 10 patents that reference this research output.

Factor VIII chimeric proteins and uses thereof

Grant US-12617839-B2

United States of America

05 May 2026

FVIII fusion protein and use thereof

Grant US-12440572-B2

United States of America

14 Oct 2025

Clotting factor preparations for delivery to intestinal tissues using a swallowable drug…

Grant JP-7692363-B2

Japan

13 Jun 2025

Conjugates of a factor VIII moiety having an oxime-containing linkage

Grant US-12324828-B2

United States of America

10 Jun 2025

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 6 additional patents.